-
Garden Reach Sh.
3,034.00 1,180.10(%) -
Enviro Infra
251.85 392.00(%) -
Waaree Energies
2,940.85 1,808.65(%) -
Multi Comm. Exc.
8,808.85 8,357.25(%) -
Welspun Living
142.00 213.10(%) -
Vodafone Idea
7.19 19.15(%) -
M T N L
57.90 101.88(%) -
Bharat Electron
409.00 240.15(%) -
Cochin Shipyard
2,120.50 1,180.45(%) -
Sammaan Capital
146.75 179.35(%) -
Netwrk.18 Media
61.82 106.01(%) -
Mazagon Dock
3,212.05 1,917.95(%) -
Hind.Aeronautics
4,791.50 3,045.95(%) -
Dixon Technolog.
14,055.70 10,613.00(%) -
Hyundai Motor I
2,145.00 2,083.60(%) -
Vishal Mega Mart
137.80 134.50(%) -
Tata Motors
678.80 1,179.05(%) -
BEML Ltd
4,422.00 2,346.35(%) -
NTPC
333.55 448.30(%) -
Data Pattern
2,805.00 1,350.50(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Novelix Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 33252.0
- ISIN : INE314I01036
-
Today’s Low
30.79 -
Today’s High
30.79

-
Open
30.79 -
Perv Close
29.33 -
52W Low
18.94 -
52W High
30.79
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
76.82
-
Div & Yield %
0.00
-
Book Value(₹)
13.04
-
Debt-Equity Ratio
4.98
-
AGM Date
24-Jun-2025
-
EPS
0.03
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
76.82
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
24.95
-
BV (₹)
13.00
-
Sales( ₹ in Cr.)
30.72
-
NP (in Cr.)
0.08
-
NP Var(%)
480.0
-
Div%
0.0
-
CPS (₹)
0.00
-
EPS (₹)
0.00
-
Traded Value (₹ in Lakhs)
76.82
-
52 Week High
30.79
-
52 Week Low
18.94
-
Price BSE
31.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
76.82
-
P/C Ratio
631.40
-
P/E Ratio
915.30
-
Price Vs.BV
0.00
-
21-Jun-2025( 03:28)
Corporate News - Novel... - Novelix Pharmaceuticals will h...
-
28-May-2025( 07:36)
Results - Announcements - Novel... - Net profit of Novelix Pharmace...
-
21-May-2025( 04:50)
Corporate News - Novel... - Novelix Pharmaceuticals will h...
-
15-Apr-2025( 10:33)
Corporate News - Novel... - Novelix Pharmaceuticals announ...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 4.49 | 1.92 | 1.14 | 1.31 | 1.50 | 3.61 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 4.49 | 1.92 | 1.14 | 1.31 | 1.50 | 3.61 |
Other Income | 0.04 | 0.00 | 0.25 | 0.00 | 0.00 | 0.11 |
Stock Adjustments | 0.37 | 0.29 | 0.28 | -0.14 | -0.02 | 0.00 |
Total Income | 4.90 | 2.21 | 1.67 | 1.17 | 1.48 | 3.72 |
EXPENDITURE : | ||||||
Raw Materials | 4.21 | 1.64 | 1.09 | 0.88 | 0.73 | 2.77 |
Power and Fuel Cost | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 |
Employee Cost | 0.13 | 0.16 | 0.14 | 0.15 | 0.13 | 0.18 |
Other Manufacturing Expenses | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 | 0.03 |
Selling and Administration Expenses | 0.34 | 0.36 | 0.38 | 0.31 | 0.35 | 0.42 |
Miscellaneous Expenses | 0.14 | 0.01 | 1.53 | 2.98 | 0.01 | 0.02 |
Employee Benefit Expenses | 0.13 | 0.16 | 0.14 | 0.15 | 0.13 | 0.18 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 4.85 | 2.21 | 3.17 | 4.36 | 1.29 | 3.41 |
Operating Profit | 0.06 | 0.00 | -1.49 | -3.19 | 0.18 | 0.31 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.06 | 0.00 | -1.49 | -3.19 | 0.18 | 0.31 |
Depreciation | 0.04 | 0.06 | 0.07 | 0.08 | 0.08 | 0.12 |
Profit Before Tax | 0.02 | -0.06 | -1.56 | -3.27 | 0.10 | 0.19 |
Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.01 | 0.00 | -0.01 | 0.00 | 0.01 | -0.10 |
Reported Net Profit | 0.01 | -0.06 | -1.56 | -3.27 | 0.09 | 0.25 |
Extraordinary Items | 0.03 | 0.00 | -0.02 | 0.00 | 0.00 | 0.09 |
Adjusted Net Profit | -0.02 | -0.06 | -1.54 | -3.27 | 0.09 | 0.16 |
Adjustment below Net Profit | 0.15 | 0.01 | 0.00 | 0.00 | -0.03 | -0.06 |
P & L Balance brought forward | -2.43 | -2.37 | -0.81 | 2.53 | 2.50 | 2.25 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.14 | 0.01 | 0.00 | 0.07 | 0.03 | -0.06 |
P & L Balance carried down | -2.41 | -2.43 | -2.37 | -0.81 | 2.53 | 2.50 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 0.01 | -0.07 | -1.93 | -4.04 | 0.12 | 0.31 |
Earnings Per Share(Adj)-Unit Curr | 0.01 | -0.07 | -1.93 | -4.04 | 0.12 | - |
Book Value | 9.08 | 8.88 | 8.94 | 10.87 | 14.90 | 14.83 |
Book Value(Adj)-Unit Curr | 9.08 | 8.88 | 8.94 | 10.87 | 14.90 | - |